Cover Image
Market Research Report

Diabetes Diagnostics

Published by Global Industry Analysts, Inc. Product code 240186
Published Content info 215 Pages
Delivery time: 1-2 business days
Price
Back to Top
Diabetes Diagnostics
Published: July 1, 2020 Content info: 215 Pages
Description

Global Diabetes Diagnostics Market to Reach $39.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Diabetes Diagnostics estimated at US$26.3 Billion in the year 2020, is projected to reach a revised size of US$39.1 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Test Strips, one of the segments analyzed in the report, is projected to record a 7% CAGR and reach US$11.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Lancets segment is readjusted to a revised 6.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $7.1 Billion, While China is Forecast to Grow at 9.1% CAGR

The Diabetes Diagnostics market in the U.S. is estimated at US$7.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$8.4 Billion by the year 2027 trailing a CAGR of 9.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Analog Glucose Monitor Segment to Record 5.3% CAGR

In the global Analog Glucose Monitor segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.8 Billion in the year 2020 will reach a projected size of US$3.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5.3 Billion by the year 2027, while Latin America will expand at a 6.5% CAGR through the analysis period. We bring years of research experience to this 18th edition of our report. The 215-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • A.Menarini Diagnostics Ltd.
  • Abbott Diabetes Care Inc.
  • Acon Laboratories Inc.
  • AgaMatrix Inc.
  • Apex Biotechnology Corporation
  • ARKRAY Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company
  • BIONIME Corporation
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • DexCom Inc.
  • Diazyme Laboratories Inc.
  • EKF Diagnostics Holdings Plc
  • HemoCue® AB
  • LifeScan, Inc.
  • Medtronic PLC
  • Nova Biomedical Corporation
  • OSANG Healthcare Co. Ltd.
  • PTS Diagnostics
  • Sanofi S.A.
  • Sanwa Kagaku Kenkyusho Co Ltd.
  • Siemens Healthineers
  • Sinocare Inc.
  • TaiDoc Technology Corporation
  • Tandem Diabetes Care Inc.
  • Terumo Corporation
  • Tosoh Bioscience Inc.
  • Trinity Biotech plc
  • Trividia Health Inc.
  • Ypsomed AG
Table of Contents
Product Code: MCP-3404

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Diabetes Diagnostics: Towards Easier, Economic, and Efficient Management of the Global Diabetes Epidemic
  • Evolution of Diabetes Testing over the Years with Key Features in Each Period
  • Growth Drivers in a Nutshell
  • Recent Market Activity
  • Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices
  • Diabetes Emerges as One of the Leading Causes of Death
  • Etiological Factors Causing Diabetes
  • Future Prospects Remain Favorable for Diabetes Diagnostics Market
  • Developed Regions Remain Primary Revenue Contributors
  • Developing Countries Continue to Offer Significant Growth Opportunities
  • Key Factors Driving Sales of Diabetes Diagnostics in Developing Regions
  • Global Competitor Market Shares
  • Diabetes Diagnostics Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
  • Stable Economic Scenario to Underpin Market Expansion
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

  • A.Menarini Diagnostics Ltd. (UK)
  • Abbott Diabetes Care, Inc. (USA)
  • Acon Laboratories, Inc. (USA)
  • AgaMatrix, Inc. (USA)
  • Apex Biotechnology Corporation (Taiwan)
  • ARKRAY, Inc. (Japan)
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • B. Braun Melsungen AG (Germany)
  • Becton, Dickinson and Company (USA)
  • BIONIME Corporation (Taiwan)
  • Bio-Rad Laboratories, Inc. (USA)
  • Danaher Corporation (USA)
  • Beckman Coulter, Inc. (USA)
  • HemoCue(r) AB (Sweden)
  • DexCom, Inc. (USA)
  • Diazyme Laboratories Inc. (USA)
  • EKF Diagnostics Holdings Plc (UK)
  • LifeScan, Inc. (USA)
  • Medtronic PLC (Ireland)
  • Nova Biomedical Corporation (USA)
  • OSANG Healthcare Co., Ltd. (South Korea)
  • Roche Diabetes Care, Inc. (USA)
  • Sanofi S.A. (France)
  • Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
  • Siemens Healthineers (Germany)
  • Sinocare, Inc. (China)
  • PTS Diagnostics (USA)
  • Trividia Health, Inc. (USA)
  • TaiDoc Technology Corporation (Taiwan)
  • Tandem Diabetes Care, Inc. (USA)
  • Terumo Corporation (Japan)
  • Tosoh Bioscience, Inc. (USA)
  • Trinity Biotech plc (Ireland)
  • Ypsomed AG (Switzerland)

3. MARKET TRENDS & DRIVERS

  • Growing Prominence of Real-Time Glucose Sensing and Monitoring Drive Robust Demand for Minimally-Invasive CGM Devices
  • CGM Market Gradually Breaks through Barriers to Adoption
  • Intensive Care Units: A Highly Promising Market for CGMs
  • Proven Efficacy for Development of Intervention Strategies Drives Demand for HbA1c Testing Devices
  • Rising Popularity of Near Patient Testing Benefits Prospects for HbA1c Devices
  • Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
  • Home HbA1c Testing: An Overview
  • Glycated Albumin: A Potential Threat to HbA1c?
  • Approval for HbA1c Testing for Diabetes Diagnosis: An Opportunity to Tap
  • Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?
  • HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants
  • ESC and ADA Release Revised Guidelines for HbA1c Testing
  • Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped Potential
  • Undiagnosed Diabetics: More Prone to Cardiovascular Diseases
  • Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices
  • Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular Complications
  • High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
  • Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
  • Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
  • Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market
  • Rising Expenditure on Diabetes Care Drives Diagnostic Devices Sales
  • Increasing Obesity Levels Underpins Market Growth
  • Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Dominate Sales
  • Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring Systems
  • Self-Monitoring/Household Blood Glucose: Sustaining Growth in Demand
  • Key Trends in the Glucose Meter/Monitoring Systems
  • Smartphone Penetration Favors SMBG Market
  • Demand for BGM Products to Witness Varying Patterns in Developed and Developing Markets
  • Barriers to Adoption of New Technology in BGM Products
  • Accuracy Issues Plague Blood Glucose Meters Market
  • Advancements in Glucose Monitoring Devices Offers a New Ray of Hope

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Diabetes Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Diabetes Diagnostics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Diabetes Diagnostics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Test Strips (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: Test Strips (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: Test Strips (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Lancets (Product Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: Lancets (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: Lancets (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Analog Glucose Monitor (Product Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 11: Analog Glucose Monitor (Product Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: Analog Glucose Monitor (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Continuous Glucose Monitor (Product Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 14: Continuous Glucose Monitor (Product Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 15: Continuous Glucose Monitor (Product Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Syringes (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 17: Syringes (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 18: Syringes (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Pens (Product Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
  • TABLE 20: Pens (Product Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 21: Pens (Product Type) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 22: Pumps (Product Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
  • TABLE 23: Pumps (Product Type) Global Historic Demand in US$ Million by Region/Country: 2012 to 2019
  • TABLE 24: Pumps (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 25: Injectors (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 26: Injectors (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 27: Injectors (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Diabetes Diagnostics Market Share (in %) by Company: 2020 & 2025
    • Market Analytics
    • TABLE 28: United States Diabetes Diagnostics Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
    • TABLE 29: Diabetes Diagnostics Market in the United States by Product Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 30: United States Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 31: Canadian Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
    • TABLE 32: Canadian Diabetes Diagnostics Historic Market Review by Product Type in US$ Million: 2012-2019
    • TABLE 33: Diabetes Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
  • JAPAN
    • TABLE 34: Japanese Market for Diabetes Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
    • TABLE 35: Diabetes Diagnostics Market in Japan: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
    • TABLE 36: Japanese Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 37: Chinese Diabetes Diagnostics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
    • TABLE 38: Diabetes Diagnostics Historic Market Analysis in China in US$ Million by Product Type: 2012-2019
    • TABLE 39: Chinese Diabetes Diagnostics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • EUROPE
    • Market Facts & Figures
    • European Diabetes Diagnostics Market: Competitor Market Share Scenario (in %) for 2020 & 2025
    • Market Analytics
    • TABLE 40: European Diabetes Diagnostics Market Demand Scenario in US$ Million by Region/Country: 2020-2027
    • TABLE 41: Diabetes Diagnostics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 42: European Diabetes Diagnostics Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 43: European Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
    • TABLE 44: Diabetes Diagnostics Market in Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
    • TABLE 45: European Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 46: Diabetes Diagnostics Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 47: French Diabetes Diagnostics Historic Market Scenario in US$ Million by Product Type: 2012-2019
    • TABLE 48: French Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
  • GERMANY
    • TABLE 49: Diabetes Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 50: German Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
    • TABLE 51: German Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 52: Italian Diabetes Diagnostics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
    • TABLE 53: Diabetes Diagnostics Historic Market Analysis in Italy in US$ Million by Product Type: 2012-2019
    • TABLE 54: Italian Diabetes Diagnostics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED KINGDOM
    • TABLE 55: United Kingdom Market for Diabetes Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
    • TABLE 56: Diabetes Diagnostics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
    • TABLE 57: United Kingdom Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
  • SPAIN
    • TABLE 58: Spanish Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
    • TABLE 59: Spanish Diabetes Diagnostics Historic Market Review by Product Type in US$ Million: 2012-2019
    • TABLE 60: Diabetes Diagnostics Market in Spain: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
  • RUSSIA
    • TABLE 61: Russian Diabetes Diagnostics Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
    • TABLE 62: Diabetes Diagnostics Market in Russia by Product Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 63: Russian Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 64: Rest of Europe Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
    • TABLE 65: Diabetes Diagnostics Market in Rest of Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
    • TABLE 66: Rest of Europe Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 67: Asia-Pacific Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 68: Diabetes Diagnostics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 69: Asia-Pacific Diabetes Diagnostics Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 70: Diabetes Diagnostics Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 71: Asia-Pacific Diabetes Diagnostics Historic Market Scenario in US$ Million by Product Type: 2012-2019
    • TABLE 72: Asia-Pacific Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
  • AUSTRALIA
    • TABLE 73: Diabetes Diagnostics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 74: Australian Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
    • TABLE 75: Australian Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • INDIA
    • TABLE 76: Indian Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
    • TABLE 77: Indian Diabetes Diagnostics Historic Market Review by Product Type in US$ Million: 2012-2019
    • TABLE 78: Diabetes Diagnostics Market in India: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
  • SOUTH KOREA
    • TABLE 79: Diabetes Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 80: South Korean Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
    • TABLE 81: Diabetes Diagnostics Market Share Distribution in South Korea by Product Type: 2012 VS 2020 VS 2027
  • REST OF ASIA-PACIFIC
    • TABLE 82: Rest of Asia-Pacific Market for Diabetes Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
    • TABLE 83: Diabetes Diagnostics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
    • TABLE 84: Rest of Asia-Pacific Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
  • LATIN AMERICA
    • TABLE 85: Latin American Diabetes Diagnostics Market Trends by Region/Country in US$ Million: 2020-2027
    • TABLE 86: Diabetes Diagnostics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
    • TABLE 87: Latin American Diabetes Diagnostics Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
    • TABLE 88: Latin American Diabetes Diagnostics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
    • TABLE 89: Diabetes Diagnostics Historic Market Analysis in Latin America in US$ Million by Product Type: 2012-2019
    • TABLE 90: Latin American Diabetes Diagnostics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • ARGENTINA
    • TABLE 91: Argentinean Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
    • TABLE 92: Diabetes Diagnostics Market in Argentina in US$ Million by Product Type: A Historic Review for the Period 2012-2019
    • TABLE 93: Argentinean Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • BRAZIL
    • TABLE 94: Diabetes Diagnostics Market in Brazil by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 95: Brazilian Diabetes Diagnostics Historic Market Scenario in US$ Million by Product Type: 2012-2019
    • TABLE 96: Brazilian Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
  • MEXICO
    • TABLE 97: Diabetes Diagnostics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 98: Mexican Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
    • TABLE 99: Mexican Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • REST OF LATIN AMERICA
    • TABLE 100: Rest of Latin America Diabetes Diagnostics Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
    • TABLE 101: Diabetes Diagnostics Market in Rest of Latin America by Product Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 102: Rest of Latin America Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • MIDDLE EAST
    • TABLE 103: The Middle East Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 104: Diabetes Diagnostics Market in the Middle East by Region/Country in US$ Million: 2012-2019
    • TABLE 105: The Middle East Diabetes Diagnostics Market Share Breakdown by Region/Country: 2012, 2020, and 2027
    • TABLE 106: The Middle East Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
    • TABLE 107: The Middle East Diabetes Diagnostics Historic Market by Product Type in US$ Million: 2012-2019
    • TABLE 108: Diabetes Diagnostics Market in the Middle East: Percentage Share Breakdown of Sales by Product Type for 2012,2020, and 2027
  • IRAN
    • TABLE 109: Iranian Market for Diabetes Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
    • TABLE 110: Diabetes Diagnostics Market in Iran: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
    • TABLE 111: Iranian Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
  • ISRAEL
    • TABLE 112: Israeli Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
    • TABLE 113: Diabetes Diagnostics Market in Israel in US$ Million by Product Type: A Historic Review for the Period 2012-2019
    • TABLE 114: Israeli Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • SAUDI ARABIA
    • TABLE 115: Saudi Arabian Diabetes Diagnostics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
    • TABLE 116: Diabetes Diagnostics Historic Market Analysis in Saudi Arabia in US$ Million by Product Type: 2012-2019
    • TABLE 117: Saudi Arabian Diabetes Diagnostics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED ARAB EMIRATES
    • TABLE 118: Diabetes Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 119: United Arab Emirates Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
    • TABLE 120: Diabetes Diagnostics Market Share Distribution in United Arab Emirates by Product Type: 2012 VS 2020 VS 2027
  • REST OF MIDDLE EAST
    • TABLE 121: Diabetes Diagnostics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 122: Rest of Middle East Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
    • TABLE 123: Rest of Middle East Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • AFRICA
    • TABLE 124: African Diabetes Diagnostics Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
    • TABLE 125: Diabetes Diagnostics Market in Africa by Product Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 126: African Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 59
Back to Top